Effect of Jawarish Falafali in Siman Mufrit (obesity)

Efficacy of Jawarish Falafali in Siman Mufrit (obesity): A single blind observational study

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/08/015349

Enrollment

Registered

2018-08-16

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E660- Obesity due to excess calories Health Condition 2: null- Patients of either gender in the age group of 18 to 60 yrs with Class I and Class II obesity (BMI 30-40 kg/m2)

Interventions

Intervention1: Jawarish Falafali: Unani Polyherbal semisolid formulation with 9 ingredients (according to Qarabadeen Majeedi) Dose of the drug: 5 gm OD daily empty stomach in morning for 60 days. Cont

Eligibility

Inclusion criteria

Inclusion criteria: Patients of either gender in the age group of 18-60 yrs with Class I and Class II obesity (BMI 30-40 kg/m2) Patient willing to participate in the study and ready to follow the instructions.

Exclusion criteria

Exclusion criteria: History of systemic illness, endocrinal disorders. BMI > 40 kg/m2. Pregnant and lactating mother.

Design outcomes

Primary

Measure	Time frame
Body Weight. BMI (body mass index) Waist and hip ratio. Timepoint: 0th 15th 30th 45th and 60th day	—

Secondary

Measure	Time frame
Lipid profileTimepoint: 0th and 60th day	—

Countries

India

Contacts

Public ContactDr Arshad Iqbal Wani

Luqman Unani Medical College, Hospital and Research Centre

arshidwani456@gmail.com9742863126

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026